The Current Ratio as of December 2025 (TTM) for IDL Diagnostics AB (publ) (IDLDX.ST) is 3.65

According to IDL Diagnostics AB (publ)’s latest financial reports and current stock price. The company's current Current Ratio is 3.65. This represents a change of -18.43% compared to the average of 4.47 of the last 4 quarters.

IDL Diagnostics AB (publ) (IDLDX.ST) Historical Current Ratio (quarterly & annually)

How has IDLDX.ST Current Ratio performed in the past?

The mean historical Current Ratio of IDL Diagnostics AB (publ) over the last ten years is 9.45. The current 3.65 Current Ratio has changed 3.76% with respect to the historical average. Over the past ten years (40 quarters), IDLDX.ST's Current Ratio was at its highest in in the December 2015 quarter at 32.17. The Current Ratio was at its lowest in in the December 2019 quarter at 1.47.

IDL Diagnostics AB (publ) (IDLDX.ST) Current Ratio by Quarter and Year

Discovering the peaks and valleys of IDL Diagnostics AB (publ) Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

IDL Diagnostics AB (publ) (IDLDX.ST) Average Current Ratio

How has IDLDX.ST Current Ratio performed in the past?

The current Current Ratio of IDL Diagnostics AB (publ) (IDLDX.ST) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

IDL Diagnostics AB (publ) (IDLDX.ST) Current Ratio vs. Peers

How is IDLDX.ST’s Current Ratio compared to its peers?

IDL Diagnostics AB (publ)’s Current Ratio is greater than Immunovia AB (publ) (1.91), greater than Luxbright AB (publ) (2.88), greater than SpectraCure AB (publ) (3.15), greater than Sprint Bioscience AB (publ) (1.13), greater than Iconovo AB (publ) (2.35), less than Spago Nanomedical AB (publ) (3.95), greater than Active Biotech AB (publ) (1.17), greater than Scandinavian Real Heart AB (Publ) (2.96), greater than Alligator Bioscience AB (publ) (0.56), greater than Pila Pharma AB (publ) (0.95),

Build a custom stock screener for IDL Diagnostics AB (publ) (IDLDX.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like IDL Diagnostics AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

IDL Diagnostics AB (publ) (IDLDX.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like IDL Diagnostics AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.